VIGL Stock: Vigil Neuroscience, Inc. Stock Price, Analysis & Insights

Get live VIGL stock price $8.05, comprehensive Vigil Neuroscience, Inc. stock analysis, charts, news, and expert forecast. Real-time VIGL stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

8.05

0.00%Today

VIGL • Vigil Neuroscience, Inc. • NASDAQ Global Select • Healthcare

Market Cap

375.71M

Volume

5.51M

52W High

8.10

52W Low

1.31

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Vigil Neuroscience, Inc., founded in 2020 and headquartered in Cambridge, Massachusetts, is a biotechnology company concentrating on microglia to develop transformative treatments for neurodegenerative diseases. The firm aims to provide disease-alter...

Contact Information

Website: https://www.vigilneuro.com
Address: 1 Broadway
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Higher growth potential with elevated volatility (Beta: 3.34)

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Vigil Neuroscience, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Vigil Neuroscience, Inc.
⚠Investors should consider how Vigil Neuroscience, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

375.71M

P/E Ratio (TTM)

-3.83

Beta

3.34

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare VIGL with peer companies:

Checkpoint Therapeutics, Inc. (CKPT)

Price: $4.26
Market cap: 367.72M

Climb Bio, Inc. (CLYM)

Price: $10.82
Market cap: 737.41M

Claritev Corporation (CTEV)

Price: $29.60
Market cap: 504.61M

G1 Therapeutics, Inc. (GTHX)

Price: $7.16
Market cap: 377.75M

iTeos Therapeutics, Inc. (ITOS)

Price: $10.15
Market cap: 448.68M

Orchard Therapeutics plc (ORTX)

Price: $16.70
Market cap: 380.11M

Revance Therapeutics, Inc. (RVNC)

Price: $3.65
Market cap: 381.02M

scPharmaceuticals Inc. (SCPH)

Price: $5.67
Market cap: 302.20M

SomaLogic, Inc. (SLGC)

Price: $2.10
Market cap: 396.23M

Y-mAbs Therapeutics, Inc. (YMAB)

Price: $8.61
Market cap: 391.22M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.